Physician

Vita Anksh, M.D.

According to 2025 Medicare claims, Vita Anksh, M.D. (NPI: 1386738680) practices endocrinology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is VITA ANKSH M D P A (NPI: 1205920444) and primary practice location at 34109-4427.

Anksh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,636 traditional Medicare patients, billed 60,590 HCPCS/CPT codes, and received $1,375,227 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,034 prescription claims across 1,089 beneficiaries totaling $4,047,152 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 3,374 claims. Open Payments data shows 127 records totaling $2,670. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $546,745 to $1,375,227. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,379,030 to $4,047,152. For DME billing, reported payments moved sharply higher in recent years, from $99,278 to $960,713.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,380	17,586	$546,745
2016	1,386	19,089	$542,331
2017	1,274	19,662	$519,054
2018	1,273	20,095	$558,408
2019	1,277	21,430	$605,559
2020	1,293	31,624	$720,326
2021	1,323	41,661	$885,422
2022	1,387	49,229	$957,337
2023	1,521	44,343	$1,075,817
2024	1,636	60,590	$1,375,227

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	828	5,004	$1,379,030
2016	813	4,138	$1,167,282
2017	831	4,468	$1,283,390
2018	808	4,319	$1,456,438
2019	682	3,138	$1,133,233
2020	700	3,523	$1,249,159
2021	978	5,964	$2,391,139
2022	1,116	7,962	$3,482,902
2023	1,161	9,441	$4,354,212
2024	1,089	9,034	$4,047,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	558	1,272	$129,556
2016	579	1,139	$113,748
2017	626	1,148	$189,170
2018	652	1,779	$320,180
2019	593	2,207	$525,899
2020	711	2,783	$653,424
2021	868	3,720	$869,801
2022	827	4,098	$939,710
2023	960	4,623	$1,123,531
2024	933	3,374	$1,201,796

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,130	2,374	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	499	723	$68
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	325	605	$60
J0897	Injection, denosumab, 1 mg	310	30,060	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,465	3,431	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	1,206	41,414	$1,470,890
Ozempic	Semaglutide	270	12,422	$375,219
Jardiance	Empagliflozin	183	13,729	$241,227
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	139	8,595	$222,439
Trulicity	Dulaglutide	118	3,814	$123,609

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	341	1,636	$721,223
J1813	Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units	N	30	124	$126,819
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	81	309	$111,637
E0784	External ambulatory infusion pump, insulin	Y	54	312	$103,922
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	124	332	$86,974

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	127	$2,670	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vita Anksh, M.D.?

Tedicare shows public-source Medicare data for Vita Anksh, M.D. (NPI 1386738680), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vita Anksh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vita Anksh, M.D.?

Vita Anksh, M.D. is linked to VITA ANKSH M D P A (billing NPI 1205920444) in the available physician profile data.

Does Vita Anksh, M.D. have Open Payments data?

Vita Anksh, M.D. has 127 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.